Experimental Med Vs Drs Choice for Pre-treated Advanced HER2+

moderators
moderators Posts: 8,739

Experimental Vic-Trastuzumab Duocarmazine Better Than Doctors' Treatment Choices for Pre-treated Advanced-Stage HER2-Positive Breast Cancer
October 5, 2021

The experimental targeted therapy medicine vic-trastuzumab duocarmazine improved progression-free survival and overall survival more than doctors' treatment choice for people diagnosed with advanced-stage HER2-positive breast cancer that had been previously treated with anti-HER2 medicine. Read more...